Growth hormone injections increase muscle and energy in people with low hormone levels. HGH therapy is used for hormone deficiencies and certain chronic conditions. Side effects like swelling and ...

Pediatric growth hormone deficiency (PGHD) is a genetic condition that affects your child’s physical development. Hormone replacement therapy can help promote growth, and a new injection now makes it ...

Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis and ...

Genotropin (somatropin) is a brand-name drug that’s prescribed for growth hormone deficiency in adults and growth failure in certain children. Genotropin comes as a powder that’s mixed with liquid and ...

March 5, 2010 — The US Food and Drug Administration (FDA) has approved a prefilled somatropin (rDNA origin) injection pen (Norditropin FlexPro, Novo Nordisk, Inc) for the treatment of growth hormone ...

Skytrofa is administered as a once weekly injection. It comes as a powder in cartridges that you load into an auto-injector device. The dosage of Skytrofa will vary based on your age, weight, and ...

Sogroya is administered by subcutaneous injection once weekly. The Food and Drug Administration (FDA) has approved Sogroya ® (somapacitan-beco) for the treatment of pediatric patients aged 2.5 years ...

Lonapegsomatropin statistically significantly reduced trunk percent fat at week 38 compared with placebo (-1.7% vs 0.4%, respectively) in adult GHD patients. The Food and Drug Administration (FDA) has ...